Zenlabs Ethica

how big is Zenlabs Ethica?

As of Jun 06, Zenlabs Ethica Ltd has a market capitalization of 21.71 Cr, with net sales of 51.42 Cr and a net profit of 0.27 Cr over the latest four quarters. The standalone balance sheet as of Mar'24 shows shareholder's funds of 10.12 Cr and total assets of 39.98 Cr.

As of Jun 06, Zenlabs Ethica Ltd has a market capitalization of 21.71 Cr, categorizing it as a Micro Cap company.<BR><BR>As of Jun 06, the company's Net Sales for the latest four quarters, which include Mar'25, Dec'24, Sep'24, and Jun'24, total 51.42 Cr. The Net Profit for the same period is 0.27 Cr. This data is presented on a Standalone basis.<BR><BR>As of Mar'24, the Standalone balance sheet shows Shareholder's Funds amounting to 10.12 Cr and Total Assets of 39.98 Cr.

What does Zenlabs Ethica do?

Zenlabs Ethica Ltd is a pharmaceutical contract marketing and trading company, categorized as a micro-cap with a market cap of Rs 21 Cr. As of March 2025, it reported net sales of 13 Cr and a net profit of 0 Cr.

Overview: <BR>Zenlabs Ethica Ltd is a pharmaceutical contract marketing and trading company that operates in the diversified commercial services industry, categorized as a micro-cap company.<BR><BR>History: <BR>Zenlabs Ethica Limited, formerly known as Neelkanth Technologies Limited, was incorporated in 1993. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 13 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap: Rs 21 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 21.00 <BR>Industry P/E: 23 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 1.22 <BR>Return on Equity: 2.59% <BR>Price to Book: 2.04<BR><BR>Contact Details: <BR>Address: Plot No 194-195 3rd Flr Pha-II, Industrial Area Ram Darbar Chandigarh Chandigarh ( U T ) : 160002 <BR>Tel: 91-172-4651105/3920738 <BR>Email: queries@zenlabsethica.com <BR>Website: http://www.zenlabsindia.com; www.zenlabsethica.com

When is the next results date for Zenlabs Ethica?

No Upcoming Board Meetings

What is the bonus history of the Zenlabs Ethica?

Zenlabs Ethica's bonus history includes a 1:20 bonus share announcement on October 11, 2018, with a record date of October 13, 2018, meaning shareholders received 1 additional share for every 20 shares held.

Zenlabs Ethica has a bonus history that includes a notable issue on October 11, 2018. The company announced a bonus in the ratio of 1:20, which means that for every 20 shares held, shareholders received 1 additional share. The record date for this bonus was October 13, 2018. If you have any more questions about Zenlabs Ethica or need further details, feel free to ask!

Has Zenlabs Ethica declared dividend?

Zenlabs Ethica Ltd has declared a 2% dividend, amounting to 0.2 per share, with an ex-date of July 29, 2022. However, the total returns over various periods have been negative, and the dividend yield remains at 0%.

Zenlabs Ethica Ltd has declared a 2% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2%<BR>- Amount per share: 0.2<BR>- Ex-date: Jul-29-2022<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -21.35%, the dividend return was 0%, resulting in a total return of -21.35%.<BR><BR>In the 1 year period, the price return was -23.56%, the dividend return was 0%, leading to a total return of -23.56%.<BR><BR>In the 2 years period, the price return was -29.74%, the dividend return was 0%, which resulted in a total return of -29.74%.<BR><BR>In the 3 years period, the price return was -1.39%, the dividend return was 0.50%, culminating in a total return of -0.89%.<BR><BR>In the 4 years period, the price return was 2.57%, the dividend return was 0.54%, resulting in a total return of 3.11%.<BR><BR>In the 5 years period, the price return was 31.82%, the dividend return was 0.98%, leading to a total return of 32.8%.<BR><BR>Overall, while Zenlabs Ethica Ltd has declared a dividend, the total returns over various periods show significant negative performance, particularly in the shorter terms, with only a modest recovery in the longer term. The dividend yield remains at 0%, indicating limited income generation from dividends relative to the share price.

Who are the peers of the Zenlabs Ethica?

Zenlabs Ethica's peers include International Ge, CMS Info Systems, NESCO, SIS, Nirlon, Esaar (India), Rapid Invest., Gemstone Invest., and Harmony Capital. Management risk varies from excellent at International Ge to below average at Zenlabs Ethica, with Nirlon showing the highest 1-year return at 22.15% and Zenlabs Ethica at -17.80%.

Peers: The peers of Zenlabs Ethica are International Ge, CMS Info Systems, NESCO, SIS, Nirlon, Esaar (India), Rapid Invest., Gemstone Invest., and Harmony Capital.<BR><BR>Quality Snapshot: Excellent management risk is observed at International Ge and the rest have varying ratings. Good management risk is found at CMS Info Systems and Nirlon, while Average management risk is present at NESCO, SIS, and Esaar (India). Below Average management risk is noted at Zenlabs Ethica, Rapid Invest., and Gemstone Invest. Growth is Average at Zenlabs Ethica and Nirlon, while Average growth is also seen at International Ge, with Below Average growth at CMS Info Systems, NESCO, SIS, and Esaar (India). The rest have Below Average growth ratings. Excellent capital structure is noted at International Ge, CMS Info Systems, NESCO, Esaar (India), Rapid Invest., Gemstone Invest., and Disha Resources, while Good capital structure is found at SIS, and Below Average at Nirlon and Zenlabs Ethica.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Nirlon at 22.15%, while Rapid Invest. has the lowest return with N/A, and Zenlabs Ethica's 1-year return is -17.80%. Additionally, the peers with negative six-month returns include NESCO, SIS, Rapid Invest., and Disha Resources.

Is Zenlabs Ethica overvalued or undervalued?

As of April 26, 2023, Zenlabs Ethica is considered very expensive and overvalued, with a PE ratio of 21.71, an EV to EBIT of 25.09, a low ROE of 2.59%, and a PEG ratio of 0.00, while its stock has underperformed the Sensex with a return of -21.76% compared to the Sensex's 7.61%.

As of 26 April 2023, the valuation grade for Zenlabs Ethica has moved from does not qualify to very expensive, indicating a significant shift in its valuation outlook. The company is currently assessed as overvalued. Key ratios include a PE ratio of 21.71, an EV to EBIT of 25.09, and a ROE of 2.59%, which highlight its high valuation relative to its earnings and equity returns.<BR><BR>In comparison to its peers, Zenlabs Ethica's PE ratio is notably higher than Life Insurance, which stands at 12.54, and Bajaj Finserv, with a PE of 35.83, indicating that while it is expensive, it is not the highest in its category. The PEG ratio of 0.00 suggests that there is no growth expected, further supporting the overvaluation claim. Additionally, Zenlabs Ethica's stock has underperformed against the Sensex over the past year, with a return of -21.76% compared to the Sensex's 7.61%, reinforcing the notion that the stock may be overpriced at its current valuation.

What is the technical trend for Zenlabs Ethica?

As of May 23, 2025, Zenlabs Ethica's trend is mildly bearish, with mixed indicators showing a mildly bullish weekly MACD but a bearish monthly MACD and daily moving averages.

As of 23 May 2025, the technical trend for Zenlabs Ethica has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands on a monthly basis are bearish, further supporting the overall bearish sentiment. The KST shows a mildly bullish trend weekly but is bearish monthly, indicating mixed signals. The Dow Theory reflects a mildly bullish trend on the weekly chart but shows no trend on the monthly chart. Overall, the current stance is mildly bearish with some mixed indicators, particularly in the weekly time frame.

Who are in the management team of Zenlabs Ethica?

As of March 2022, the management team of Zenlabs Ethica includes Sanjeev Kumar (Managing Director & CEO), Him Jyoti (Director), Ashok Kumar Gupta (Independent Director), Sanjay Dhir (Whole Time Director & CFO), Anurag Malhotra (Independent Director), Kuldeep Singh (Director), Hitesh Popatlal Oswal (Executive Director), and Akshay Saxena (Company Secretary & Compliance Officer). Each member plays a key role in the company's governance and operations.

As of March 2022, the management team of Zenlabs Ethica includes the following members:<BR><BR>1. Sanjeev Kumar - Managing Director & CEO<BR>2. Him Jyoti - Director<BR>3. Ashok Kumar Gupta - Independent Director<BR>4. Sanjay Dhir - Whole Time Director & CFO<BR>5. Anurag Malhotra - Independent Director<BR>6. Kuldeep Singh - Director<BR>7. Hitesh Popatlal Oswal - Executive Director<BR>8. Akshay Saxena - Company Secretary & Compliance Officer<BR><BR>Each member holds a significant position within the company, contributing to its governance and operational management.

Who are the top shareholders of the Zenlabs Ethica?

The top shareholders of Zenlabs Ethica are Preet Remedies Limited with 26.58%, followed by public shareholder Hitesh Popatlal Oswal at 6.79%. Individual investors collectively own 41.03%, with no mutual funds or foreign institutional investors holding shares.

The top shareholders of Zenlabs Ethica include Preet Remedies Limited, which holds the largest share at 26.58%. The highest public shareholder is Hitesh Popatlal Oswal, with a holding of 6.79%. Additionally, individual investors collectively hold 41.03% of the company's shares. There are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

How has been the historical performance of Zenlabs Ethica?

Zenlabs Ethica has experienced a decline in net sales and profits from Mar'22 to Mar'25, with net sales dropping from 69.09 Cr to 51.42 Cr and profit after tax decreasing from 1.26 Cr to 0.27 Cr. However, cash flow from operations improved significantly, rising to 3.00 Cr in Mar'25 from a negative 9.00 Cr in Mar'24.

Answer:<BR>The historical performance of Zenlabs Ethica shows a declining trend in net sales and profit over the past few years, with net sales decreasing from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. The total operating income followed a similar pattern, dropping from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. Operating profit (PBDIT) also saw fluctuations, peaking at 3.04 Cr in Mar'23 before falling to 2.61 Cr in Mar'25. Profit before tax decreased from 1.89 Cr in Mar'19 to 0.43 Cr in Mar'25, while profit after tax declined from 1.26 Cr in Mar'19 to 0.27 Cr in Mar'25. The earnings per share (EPS) reflected this downward trend, decreasing from 1.94 in Mar'19 to 0.41 in Mar'25. <BR><BR>In terms of assets and liabilities, total assets increased from 33.65 Cr in Mar'20 to 40.38 Cr in Mar'25, while total liabilities also rose from 31.75 Cr in Mar'21 to 40.38 Cr in Mar'25. The company maintained a consistent share capital of 6.51 Cr over the years, and reserves grew from 0.90 Cr in Mar'20 to 3.92 Cr in Mar'25. Cash flow from operating activities improved to 3.00 Cr in Mar'25 from a negative 9.00 Cr in Mar'24, indicating a recovery in operational cash generation. Overall, while Zenlabs Ethica has experienced challenges in revenue and profit, there are signs of improvement in cash flow from operations.<BR><BR>Breakdown:<BR>Zenlabs Ethica's financial performance has shown a notable decline in net sales, which fell from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25, reflecting a consistent downward trend over the years. Total operating income mirrored this decline, decreasing from 69.09 Cr to 51.42 Cr in the same period. Operating profit (PBDIT) peaked at 3.04 Cr in Mar'23 but subsequently dropped to 2.61 Cr in Mar'25. Profit before tax also decreased significantly from 1.89 Cr in Mar'19 to 0.43 Cr in Mar'25, while profit after tax fell from 1.26 Cr to 0.27 Cr over the same timeframe. Earnings per share (EPS) declined from 1.94 in Mar'19 to 0.41 in Mar'25, indicating reduced profitability for shareholders. On the balance sheet, total assets increased from 33.65 Cr in Mar'20 to 40.38 Cr in Mar'25, alongside a rise in total liabilities from 31.75 Cr to 40.38 Cr. The company maintained a stable share capital of 6.51 Cr and saw its reserves grow from 0.90 Cr to 3.92 Cr. Notably, cash flow from operating activities improved to 3.00 Cr in Mar'25, recovering from a negative 9.00 Cr in Mar'24, suggesting a positive shift in operational cash generation despite the overall challenges in revenue and profit.

Are Zenlabs Ethica Ltd latest results good or bad?

Zenlabs Ethica Ltd's latest results are largely negative, showing a net profit of ₹0.04 crore with a 20% year-on-year decline, despite a 33.33% sequential growth. Revenue also decreased by 6.89% year-on-year, and the low profit margin and return on equity indicate significant financial challenges.

Zenlabs Ethica Ltd's latest results present a mixed picture, but overall, they lean towards the negative side. In Q2 FY26, the company reported a net profit of ₹0.04 crore, which reflects a positive sequential growth of 33.33% compared to the previous quarter. However, this figure represents a significant decline of 20% year-on-year, indicating ongoing challenges in profitability.<BR><BR>Revenue for the same quarter was ₹12.43 crore, showing an 8.28% increase quarter-on-quarter, but a concerning 6.89% decrease compared to the same quarter last year. This trend of declining revenues is troubling, as it suggests the company is struggling to maintain its market position.<BR><BR>The profit after tax (PAT) margin remains extremely low at 0.32%, which provides little cushion against operational disruptions. Additionally, the return on equity (ROE) has dropped to a mere 2.37%, indicating severe capital inefficiency and a lack of value creation for shareholders.<BR><BR>Overall, while there are slight improvements in sequential performance, the year-on-year declines in both revenue and profit, coupled with very thin margins and weak returns on equity, suggest that Zenlabs Ethica is facing significant operational and financial challenges. Investors should approach the company with caution given these results.

Should I buy, sell or hold Zenlabs Ethica Ltd?

Why is Zenlabs Ethica Ltd falling/rising?

As of 17-Mar, Zenlabs Ethica Ltd's stock price is declining, currently at 19.05, reflecting a significant drop over various periods and underperforming compared to the Sensex. The stock is trading below all moving averages, indicating a bearish trend, and investor participation has sharply decreased.

As of 17-Mar, Zenlabs Ethica Ltd's stock price is falling, currently at 19.05, which reflects a decrease of 0.51 or 2.61%. This decline is evident in the stock's performance over various periods, such as a 12.77% drop over the past week and a 6.98% decrease over the past month. Year-to-date, the stock has fallen by 4.27%, while over the last year, it has experienced a significant decline of 40.08%. <BR><BR>The stock is also underperforming compared to the Sensex, which has only decreased by 2.73% in the last week. Furthermore, Zenlabs Ethica is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. <BR><BR>Investor participation has notably decreased, with delivery volume on March 16 dropping by 98.22% compared to the 5-day average, suggesting a lack of interest from investors. Despite being liquid enough for trading, these factors collectively contribute to the stock's downward movement.

Why is Zenlabs Ethica Ltd falling/rising?

As of 18-Mar, Zenlabs Ethica Ltd's stock price is at 19.60, showing a slight increase of 0.12 (0.62%). However, the stock has a negative performance trend, down 3.92% over the past week and 37.76% over the past year, indicating a bearish outlook and reduced investor interest.

As of 18-Mar, Zenlabs Ethica Ltd's stock price is currently at 19.60, reflecting a change of 0.12 (0.62%) upward. Despite this slight increase, the stock has shown a negative performance trend over various periods. Over the past week, it has decreased by 3.92%, and in the last month, it has fallen by 4.25%. Year-to-date, the stock is down 1.51%, and it has experienced a significant decline of 37.76% over the past year.<BR><BR>Additionally, the stock is underperforming compared to the sector, with a performance today that is 0.73% lower than its peers. It is also trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume dropping by 95.79% compared to the 5-day average, suggesting reduced interest in trading the stock. <BR><BR>Overall, while there is a minor uptick in the stock price today, the broader context indicates a persistent downward trend and lack of investor confidence in Zenlabs Ethica Ltd.

Why is Zenlabs Ethica Ltd falling/rising?

As of 19-Mar, Zenlabs Ethica Ltd's stock price is currently rising at 19.08, indicating a potential trend reversal after previous declines. However, it remains below key moving averages and has seen a significant drop in investor participation, suggesting caution may be warranted despite the recent increase.

As of 19-Mar, Zenlabs Ethica Ltd's stock price is rising, with a current price of 19.08, reflecting a change of 0.07 (0.37%) upwards. This increase comes after two consecutive days of decline, indicating a potential trend reversal. Additionally, the stock has outperformed its sector by 4.21% today, which may contribute to the positive movement in its price.<BR><BR>However, it is important to note that despite this rise, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting an overall downward trend in the longer term. Furthermore, the stock has experienced a significant drop in investor participation, with delivery volume on 18 March falling by 79.7% compared to the 5-day average. This decline in trading activity may indicate a lack of confidence among investors, which could counterbalance the recent price increase.<BR><BR>Overall, while the stock is currently rising, the broader context of its performance over various time frames and the decrease in investor participation suggests that caution may still be warranted.

Why is Zenlabs Ethica Ltd falling/rising?

As of 20-Mar, Zenlabs Ethica Ltd's stock price is Rs 18.22, down 4.51%, and has significantly underperformed with declines of 6.32% over the past week and 40.65% over the past year. The stock is trading below all key moving averages and is close to its 52-week low, indicating a bearish trend and decreased investor interest.

As of 20-Mar, Zenlabs Ethica Ltd's stock price is falling, currently at Rs 18.22, which reflects a decrease of Rs 0.86 or 4.51%. The stock has underperformed significantly over various time periods, with a decline of 6.32% over the past week and 13.36% over the past month. Year-to-date, the stock is down 8.44%, and it has experienced a substantial drop of 40.65% over the past year. <BR><BR>Additionally, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock is also close to its 52-week low, being only 1.21% away from it. Investor participation has decreased significantly, with delivery volume on March 19 dropping by 73.47% compared to the 5-day average, suggesting a lack of interest from investors. Overall, these factors contribute to the stock's downward movement.

Why is Zenlabs Ethica Ltd falling/rising?

As of 23-Mar, Zenlabs Ethica Ltd's stock price is currently at Rs 18.78, reflecting a short-term increase of 3.07%. However, it has underperformed over the past year and is trading below its moving averages, indicating potential long-term challenges.

As of 23-Mar, Zenlabs Ethica Ltd's stock price is rising, currently at Rs 18.78, reflecting an increase of Rs 0.56 or 3.07%. This rise is notable as the stock has outperformed its sector by 6.87% today, despite the broader market conditions. However, it is important to consider that the stock has been underperforming over various time frames, with a year-to-date decline of 5.63% and a significant drop of 40.92% over the past year. <BR><BR>Additionally, the stock is currently trading lower than its moving averages across multiple periods, indicating a longer-term downward trend. The stock is also close to its 52-week low, being only 4.15% away from it. Furthermore, there has been a marked decrease in investor participation, with delivery volume dropping by 89.85% compared to the 5-day average. <BR><BR>Overall, while the stock is experiencing a short-term rise today, the longer-term performance and declining investor interest suggest underlying challenges that may affect its stability moving forward.

Why is Zenlabs Ethica Ltd falling/rising?

As of 24-Mar, Zenlabs Ethica Ltd's stock price is Rs. 18.50, showing a slight increase but significant declines over various time frames, including a 46.42% drop over the past year. Despite a recent uptick and increased investor participation, the stock continues to trade below key moving averages and underperforms its sector.

As of 24-Mar, Zenlabs Ethica Ltd's stock price is currently at Rs. 18.50, reflecting a slight increase of Rs. 0.06 or 0.33%. Despite this recent uptick, the stock has been experiencing significant downward pressure over various time frames. Over the past week, it has fallen by 5.03%, and in the last month, it has decreased by 7.31%. Year-to-date, the stock is down 7.04%, and it has seen a dramatic decline of 46.42% over the past year.<BR><BR>Today, the stock hit a new 52-week low of Rs. 16.5, indicating ongoing struggles. Although it has gained 1.54% over the last two days, this is in the context of a broader trend where it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day). Furthermore, the stock underperformed its sector by 1.99% today, which suggests that while there may be some short-term gains, the overall performance remains weak compared to the sector.<BR><BR>On a more positive note, there has been a notable increase in investor participation, with delivery volume rising by 225.67% against the 5-day average, indicating a potential increase in interest from investors. However, the overall liquidity remains stable, allowing for trades without significant issues.<BR><BR>In summary, while there is a minor rise in the stock price today, the overall trend indicates significant declines over longer periods, compounded by recent lows and underperformance relative to the sector.

Why is Zenlabs Ethica Ltd falling/rising?

As of 25-Mar, Zenlabs Ethica Ltd's stock price is rising to Rs 19.00, reflecting a 10.66% increase. This rise is driven by strong sector performance and significant intraday gains, despite a longer-term decline in stock value.

As of 25-Mar, Zenlabs Ethica Ltd's stock price is rising, currently at Rs 19.00, reflecting a change of Rs 1.83 or 10.66% increase. This upward movement can be attributed to several factors observed today. The stock outperformed its sector by 7.74%, indicating strong relative performance. It opened with a gain of 2.04% and reached an intraday high of Rs 19.56, which is a significant increase of 13.92%. <BR><BR>Despite the positive performance today, it is important to note that the stock has experienced a decline over longer periods, with a year-to-date drop of 4.52% and a staggering 43.28% decrease over the past year. However, today's trading has shown high volatility, with an intraday volatility of 5.67%, suggesting active trading and investor interest. <BR><BR>Additionally, the finance/NBFC sector, in which Zenlabs operates, has gained by 2.91%, which may contribute to the stock's positive movement. However, there is a noted decrease in investor participation, with delivery volume falling by 0.07% against the 5-day average, which could indicate caution among investors despite today's rise. Overall, the stock's rise today is primarily driven by strong performance relative to its sector and significant intraday gains.

Which are the latest news on Zenlabs Ethica?